Skip to main content
Premium Trial:

Request an Annual Quote

Boyd Mulvey, Steven Deitcher, Bradley Sparks, William Hammond, Kevin Johnson, Giannni Garotta, Cynthia Helphingstine, Debra Hutson, Steve Owings, Neil Hocking, William Sullivan

Premium

Boyd Mulvey, CEO and founder of Create Partners, joins the board of directors of NextGen Sciences, the company said last week.


Steven Deitcher has become vice president for medical affairs at Nuvelo, the Sunnyvale, Calif.-based company said last week. He will be responsible for all aspects of the company’s clinical programs. Deitcher comes to Nuvelo from The Cleveland Clinic Foundation, where he was head of hematology and coagulation medicine. He holds an MD and BS from Northwestern University Medical School.


Bradley Sparks and William Hammond have been appointed to the board of directors of VizX Labs, the Seattle-based bioinformatics company said last week. Sparks, who was also elected chairman of the board, is managing director of Sunburst Growth Ventures, which focuses on emerging biotechnology companies. He was trained in engineering at the US Military Academy, West Point. Hammond was most recently president, medical director, and CEO of The Hope Heart Institute. He holds an MD from Tufts University and a BA from Harvard University.


Kevin Johnson and Giannni Garotta have joined Index Ventures as executives in residence, and Ennio Ongini as venture advisor, the European venture capital firm said last week. Johnson was most recently chief technology officer of Cambridge Antibody Technologies. Garotta used to be vice president for academic collaborations at Serono. Ongini is currently head of discovery at Nicox.


Cynthia Helphingstine has become vice president of business development for Inproteo. Prior to joining Inproteo, she was a consultant at Biotron Group, which she helped found.


Debra Hutson has become director of quality assurance, and Steve Owings becomes director of business development for the diagnostics business at Epoch Biosciences, the company said.

Hutson was formerly director for quality assurance of manufacturing at CombiMatrix. Owings was vice president of sales and marketing at Visible Genetics.


Neil Hocking joins Gene Logic’s new UK-based subsidiary as executive director for business development, the company said. He previously worked for Sanyo, MDL, and Celera Genomics.


William Sullivan joins Ciphergen’s new diagnostics division as vice president of operations, the company said. Previously, he was vice president of diagnostic manufacturing at Visible Genetics. He holds an AB degree from Holy Cross.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.